Reduced cardioprotective action of adiponectin in high-fat diet-induced type II diabetic mice and its underlying mechanisms

Antioxidants and Redox Signaling

Volumn 15, Issue 7, 2011, Pages 1779-1788

  Yi, Wei ^a,b   Sun, Yang ^a,c   Gao, Erhe ^a   Wei, Xufeng ^a,b   Lau, Wayne Bond ^a   Zheng, Qijun ^a,b   Wang, Yajing ^a   Yuan, Yuexing ^a   Wang, Xiaoliang ^a   Tao, Ling ^b   Li, Rong ^c   Koch, Walter ^b   Ma, Xin Liang ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Department of Cardiovascular Surgery ^*  (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; ADIPONECTIN; CASPASE 3; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PEROXYNITRITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG MEGADOSE; HEART FUNCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; LIPID DIET; LOW DRUG DOSE; MALE; MOUSE; NITRATIVE STRESS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; REPERFUSION INJURY; TREATMENT RESPONSE;

ACETYL-COA CARBOXYLASE; ADENYLATE KINASE; ADIPONECTIN; ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; CARDIOTONIC AGENTS; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; ENZYME ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PEROXYNITROUS ACID; SUPEROXIDES; VENTRICULAR DYSFUNCTION, LEFT;

ANIMALIA; MUS;

EID: 79959509426     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2010.3722     Document Type: Article

References (29)

1. Basu R, Pajvani UB, Rizza RA, and Scherer PE. Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects. Diabetes 56: 2174-2177, 2007. (Pubitemid 47195840)
2. Beckman JS and Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271: C1424-C1437, 1996.
3. Behrends M, Schulz R, Post H, Alexandrov A, Belosjorow S, Michel MC, and Heusch G. Inconsistent relation of MAPK activation to infarct size reduction by ischemic preconditioning in pigs. Am J Physiol Heart Circ Physiol 279: H1111-H1119, 2000.
4. Berg AH, Combs TP, Du X, Brownlee M, and Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7: 947-953, 2001. (Pubitemid 32756433)
5. Bruce CR, Mertz VA, Heigenhauser GJ, and Dyck DJ. The stimulatory effect of globular adiponectin on insulinstimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjects. Diabetes 54: 3154-3160, 2005. (Pubitemid 43334369)
6. Chen H, Montagnani M, Funahashi T, Shimomura I, and Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 278: 45021-45026, 2003. (Pubitemid 37377262)
7. Chen MB, McAinch AJ, Macaulay SL, Castelli LA, O'Brien PE, Dixon JB, Cameron-Smith D, Kemp BE, and Steinberg GR. Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics. J Clin Endocrinol Metab 90: 3665-3672, 2005. (Pubitemid 41014341)
8. Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, Jiao X, Scalia R, Kiss L, Szabo C, Kimura H, Chow CW, and Lefer DJ. Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 104: 15560-15565, 2007. (Pubitemid 47502956)
9. Frystyk J, Berne C, Berglund L, Jensevik K, Flyvbjerg A, and Zethelius B. Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. J Clin Endocrinol Metab 92: 571-576, 2007.
10. Goldstein BJ and Scalia R. Adipokines and vascular disease in diabetes. Curr Diab Rep 7: 25-33, 2007. (Pubitemid 46344186)
11. Goldstein BJ, Scalia RG, and Ma XL. Protective vascular and myocardial effects of adiponectin. Nat Clin Pract Cardiovasc Med 6: 27-35, 2009.
12. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, and Matsuzawa Y. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20: 1595-1599, 2000. (Pubitemid 30353893)
13. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, and Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116: 1784-1792, 2006. (Pubitemid 44033298)
14. Kim YM, Bombeck CA, and Billiar TR. Nitric oxide as a bifunctional regulator of apoptosis. Circ Res 84: 253-256, 1999. (Pubitemid 29095565)
15. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H, Nakamura T, Funahashi T, and Matsuzawa Y. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23: 85-89, 2003. (Pubitemid 36091630)
16. Li R, Xu M, Wang X, Wang Y, Lau WB, Yuan Y, Yi W, Wei X, Lopez BL, Christopher TA, Wang XM, and Ma XL. Reduced vascular responsiveness to adiponectin in hyperlipidemic rats-mechanisms and significance. J Mol Cell Cardiol 49: 508-515, 2010.
17. Mullen KL, Pritchard J, Ritchie I, Snook LA, Chabowski A, Bonen A, Wright D, and Dyck DJ. Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats. Am J Physiol Regul Integr Comp Physiol 296: R243-R251, 2009.
18. Mullen KL, Smith AC, Junkin KA, and Dyck DJ. Globular adiponectin resistance develops independently of impaired insulin-stimulated glucose transport in soleus muscle from high-fat-fed rats. Am J Physiol Endocrinol Metab 293: E83-E90, 2007. (Pubitemid 47105920)
19. Ouchi N, Shibata R, and Walsh K. Cardioprotection by adiponectin. Trends Cardiovasc Med 16: 141-146, 2006. (Pubitemid 43867326)
20. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, and Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291: 1730-1737, 2004. (Pubitemid 38489895)
21. Rodriguez A, Catalan V, Becerril S, Gil MJ, Mugueta C, Gomez-Ambrosi J, and Fruhbeck G. Impaired adiponectin-AMPK signalling in insulin-sensitive tissues of hypertensive rats. Life Sci 83: 540-549, 2008.
22. Shibata R, Numaguchi Y, Matsushita K, Sone T, Kubota R, Ohashi T, Ishii M, Kihara S, Walsh K, Ouchi N, and Murohara T. Usefulness of adiponectin to predict myocardial salvage following successful reperfusion in patients with acute myocardial infarction. Am J Cardiol 101: 1712-1715, 2008.
23. Shibata R, Ouchi N, Kihara S, Sato K, Funahashi T, and Walsh K. Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling. J Biol Chem 279: 28670-28674, 2004. (Pubitemid 38900150)
24. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, Funahashi T, Ouchi N, and Walsh K. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK-and COX-2-dependent mechanisms. Nat Med 11: 1096-1103, 2005. (Pubitemid 41486832)
25. Tao L, Gao E, Jiao X, Yuan Y, Li S, Christopher TA, Lopez BL, Koch W, Chan L, Goldstein BJ, and Ma XL. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation 115: 1408-1416, 2007. (Pubitemid 46648376)
26. Venables MC and Jeukendrup AE. Physical inactivity and obesity: links with insulin resistance and type 2 diabetes mellitus. Diabetes Metab Res Rev 25 Suppl 1: S18-S23, 2009.
27. Wang Y, Gao E, Tao L, Lau WB, Yuan Y, Goldstein BJ, Lopez BL, Christopher TA, Tian R, Koch W, and Ma XL. AMPactivated protein kinase deficiency enhances myocardial ischemia/reperfusion injury but has minimal effect on the antioxidant/antinitrative protection of adiponectin. Circulation 119: 835-844, 2009.
28. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, and Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288-1295, 2002. (Pubitemid 35373562)
29. Zhu M, Miura J, Lu LX, Bernier M, DeCabo R, Lane MA, Roth GS, and Ingram DK. Circulating adiponectin levels increase in rats on caloric restriction: the potential for insulin sensitization. Exp Gerontol 39: 1049-1059, 2004. (Pubitemid 38952885)